Medline (MDLN) reported $28.4B in revenue for fiscal 2025, +11.5% year on year. That ranks #190 by revenue among 2853 SEC filers and #25 in Healthcare. Net income was $1.2B, a net margin of 4.1%. Revenue has grown 10.6% a year on average since 2023 ($23.2B then). The fiscal 2025 balance sheet shows $38.5B in total assets, $1.9B in cash and $12.5B in long-term debt.
Scale corrected: the company's XBRL data reports net income (÷10³) without the scale factor (for example "4,801" for 4.8 billion). The figures are shown at the corrected scale; each links to the filing it comes from.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenues | $28.4B | +11.5% | FY20252025-12-31 |
| Gross profitGrossProfit | $7.5B | +7.8% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | $2.2B | +3.1% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $1.2B | −0.5% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $1.7B | −1.4% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $447M | +26.3% | FY20252025-12-31 |
| Total assetsAssets | $38.5B | +7.0% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $10.7B | — | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $1.9B | +874.4% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $12.5B | −24.0% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-28 | $7.4B | $239M | Open → |
| Q2 20262026-06-27 | $7.7B | $139M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 92 of 161 companies compared | 4.1% | |
| Operating marginRank 97 of 160 companies compared | 7.8% | |
| R&D as share of revenueRank 98 of 102 companies compared | 0.3% | |
| Cash as share of revenueRank 113 of 160 companies compared | 6.8% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Medline Inc.
- Ticker
- MDLN
- Exchange
- Nasdaq
- SIC classification
- Surgical & Medical Instruments & Apparatus (3841)
- Fiscal year end
- 12-31
- CIK
- 0002046386
Filings
- 10-QAug 5, 2026Open filing →
- 10-QMay 6, 2026Open filing →
- 10-KFeb 25, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| AmgenAMGN | $36.8B | $7.7B |
| MedtronicMDT | $36.4B | $4.8B |
| Gilead SciencesGILD | $29.4B | $8.5B |
| MedlineMDLN | $28.4B | $1.2B |
| StrykerSYK | $25.1B | $3.2B |
| 3MMMM | $24.9B | $3.3B |
| Fresenius Medical CareFMS | $22.2B | $1.1B |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Medline — Key figures |url=https://companiesranked.com/en/company/medline |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Medline — Key figures. CompaniesRanked. https://companiesranked.com/en/company/medlineBibTeX
@misc{companiesranked-en-company-medline-2026,
author = {{CompaniesRanked}},
title = {{Medline — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/medline}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0002046386-26-000009 · February 25, 2026
{{cite web |title=Medline — Key figures — 10-K (0002046386-26-000009) |url=https://www.sec.gov/Archives/edgar/data/2046386/000204638626000009/mdln-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-25}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.